Oncolytic Virus CDMO Services Market Size, Share & Industry Analysis, By Service Type (Development & Technology-Transfer Services, Cell & Virus Banking Services, Manufacturing Services, and Analytical Testing & CMC Support Services), By Virus (Adenoviridae, Herpesviridae, Poxviridae, and Reoviridae), By Development Stage (Preclinical & IND-enabling, Phase I, Phase II, Phase III & Registration, and Commercial & Post-approval), By Sponsor Type (Small & Mid-sized Biotechnology Companies, Large Pharmaceutical Companies, and Academic & Research Institutions), and Regional Forecast, 2026-2034

Last Updated: August 28, 2026 | Format: PDF | Report ID: FBI119065

Buy Now

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Challenges
5. Market Trends
Key Insights
1. Technological Advancements in Oncolytic Virus CDMO Services
2. Key Industry Developments - Mergers, Acquisitions & Partnerships
Global Oncolytic Virus CDMO Services Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Service Type
  1. Development & Technology-Transfer Services
  2. Cell & Virus Banking Services
  3. Manufacturing Services
  4. Analytical Testing & CMC Support Services
2. Market Analysis, Insights and Forecast – By Virus
  1. Adenoviridae
  2. Herpesviridae
  3. Poxviridae
  4. Reoviridae
  5. Others
3. Market Analysis, Insights and Forecast – By Development Stage
  1. Preclinical & IND-enabling
  2. Phase I
  3. Phase II
  4. Phase III & Registration
  5. Commercial & Post-approval
4. Market Analysis, Insights and Forecast – By Sponsor Type
  1. Small & Mid-sized Biotechnology Companies
  2. Large Pharmaceutical & Biopharmaceutical Companies
  3. Academic & Research Institutions
  4. Others
5. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Oncolytic Virus CDMO Services Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Service Type
  1. Development & Technology-Transfer Services
  2. Cell & Virus Banking Services
  3. Manufacturing Services
  4. Analytical Testing & CMC Support Services
2. Market Analysis, Insights and Forecast – By Virus
  1. Adenoviridae
  2. Herpesviridae
  3. Poxviridae
  4. Reoviridae
  5. Others
3. Market Analysis, Insights and Forecast – By Development Stage
  1. Preclinical & IND-enabling
  2. Phase I
  3. Phase II
  4. Phase III & Registration
  5. Commercial & Post-approval
4. Market Analysis, Insights and Forecast – By Sponsor Type
  1. Small & Mid-sized Biotechnology Companies
  2. Large Pharmaceutical & Biopharmaceutical Companies
  3. Academic & Research Institutions
  4. Others
5. Market Analysis, Insights and Forecast – By Country
  1. U.S.
    1. By Virus
  2. Canada
    1. By Virus
Europe Oncolytic Virus CDMO Services Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Service Type
  1. Development & Technology-Transfer Services
  2. Cell & Virus Banking Services
  3. Manufacturing Services
  4. Analytical Testing & CMC Support Services
2. Market Analysis, Insights and Forecast – By Virus
  1. Adenoviridae
  2. Herpesviridae
  3. Poxviridae
  4. Reoviridae
  5. Others
3. Market Analysis, Insights and Forecast – By Development Stage
  1. Preclinical & IND-enabling
  2. Phase I
  3. Phase II
  4. Phase III & Registration
  5. Commercial & Post-approval
4. Market Analysis, Insights and Forecast – By Sponsor Type
  1. Small & Mid-sized Biotechnology Companies
  2. Large Pharmaceutical & Biopharmaceutical Companies
  3. Academic & Research Institutions
  4. Others
5. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. U.K.
    1. By Virus
  2. Germany
    1. By Virus
  3. France
    1. By Virus
  4. Spain
    1. By Virus
  5. Italy
    1. By Virus
  6. Scandinavia
    1. By Virus
  7. Rest of Europe
    1. By Virus
Asia Pacific Oncolytic Virus CDMO Services Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Service Type
  1. Development & Technology-Transfer Services
  2. Cell & Virus Banking Services
  3. Manufacturing Services
  4. Analytical Testing & CMC Support Services
2. Market Analysis, Insights and Forecast – By Virus
  1. Adenoviridae
  2. Herpesviridae
  3. Poxviridae
  4. Reoviridae
  5. Others
3. Market Analysis, Insights and Forecast – By Development Stage
  1. Preclinical & IND-enabling
  2. Phase I
  3. Phase II
  4. Phase III & Registration
  5. Commercial & Post-approval
4. Market Analysis, Insights and Forecast – By Sponsor Type
  1. Small & Mid-sized Biotechnology Companies
  2. Large Pharmaceutical & Biopharmaceutical Companies
  3. Academic & Research Institutions
  4. Others
5. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. Japan
    1. By Virus
  2. Australia
    1. By Virus
  3. China
    1. By Virus
  4. India
    1. By Virus
  5. Southeast Asia
    1. By Virus
  6. Rest of Asia Pacific
    1. By Virus
Latin America Oncolytic Virus CDMO Services Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Service Type
  1. Development & Technology-Transfer Services
  2. Cell & Virus Banking Services
  3. Manufacturing Services
  4. Analytical Testing & CMC Support Services
2. Market Analysis, Insights and Forecast – By Virus
  1. Adenoviridae
  2. Herpesviridae
  3. Poxviridae
  4. Reoviridae
  5. Others
3. Market Analysis, Insights and Forecast – By Development Stage
  1. Preclinical & IND-enabling
  2. Phase I
  3. Phase II
  4. Phase III & Registration
  5. Commercial & Post-approval
4. Market Analysis, Insights and Forecast – By Sponsor Type
  1. Small & Mid-sized Biotechnology Companies
  2. Large Pharmaceutical & Biopharmaceutical Companies
  3. Academic & Research Institutions
  4. Others
5. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. Brazil
    1. By Virus
  2. Mexico
    1. By Virus
  3. Rest of Latin America
    1. By Virus
Middle East & Africa Oncolytic Virus CDMO Services Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Service Type
  1. Development & Technology-Transfer Services
  2. Cell & Virus Banking Services
  3. Manufacturing Services
  4. Analytical Testing & CMC Support Services
2. Market Analysis, Insights and Forecast – By Virus
  1. Adenoviridae
  2. Herpesviridae
  3. Poxviridae
  4. Reoviridae
  5. Others
3. Market Analysis, Insights and Forecast – By Development Stage
  1. Preclinical & IND-enabling
  2. Phase I
  3. Phase II
  4. Phase III & Registration
  5. Commercial & Post-approval
4. Market Analysis, Insights and Forecast – By Sponsor Type
  1. Small & Mid-sized Biotechnology Companies
  2. Large Pharmaceutical & Biopharmaceutical Companies
  3. Academic & Research Institutions
  4. Others
5. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. South Africa
    1. By Virus
  2. GCC
    1. By Virus
  3. Rest of Middle East & Africa
    1. By Virus
Competitive Analysis
1. Global Market Share Analysis (2025)
2. Company Profiles (Overview, Products, SWOT analysis, Recent developments, strategies, financials (based on availability)
  1. FUJIFILM Biotechnologies (U.S.)
  2. Lonza Group AG (Switzerland)
  3. Recipharm AB (Sweden)
  4. IDT Biologika GmbH (Germany)
  5. WuXi Advanced Therapies (U.S.)
  6. ABL, Inc. (U.S.)
  7. uBriGene Biosciences Inc. (U.S.)
  8. OBiO Technology Corp., Ltd. (China)
  9. Exothera S.A. (Belgium)
  10. NAOBIOS (France)

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Challenges
5. Market Trends
Key Insights
1. Technological Advancements in Oncolytic Virus CDMO Services
2. Key Industry Developments - Mergers, Acquisitions & Partnerships
Global Oncolytic Virus CDMO Services Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Service Type
  1. Development & Technology-Transfer Services
  2. Cell & Virus Banking Services
  3. Manufacturing Services
  4. Analytical Testing & CMC Support Services
2. Market Analysis, Insights and Forecast – By Virus
  1. Adenoviridae
  2. Herpesviridae
  3. Poxviridae
  4. Reoviridae
  5. Others
3. Market Analysis, Insights and Forecast – By Development Stage
  1. Preclinical & IND-enabling
  2. Phase I
  3. Phase II
  4. Phase III & Registration
  5. Commercial & Post-approval
4. Market Analysis, Insights and Forecast – By Sponsor Type
  1. Small & Mid-sized Biotechnology Companies
  2. Large Pharmaceutical & Biopharmaceutical Companies
  3. Academic & Research Institutions
  4. Others
5. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Oncolytic Virus CDMO Services Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Service Type
  1. Development & Technology-Transfer Services
  2. Cell & Virus Banking Services
  3. Manufacturing Services
  4. Analytical Testing & CMC Support Services
2. Market Analysis, Insights and Forecast – By Virus
  1. Adenoviridae
  2. Herpesviridae
  3. Poxviridae
  4. Reoviridae
  5. Others
3. Market Analysis, Insights and Forecast – By Development Stage
  1. Preclinical & IND-enabling
  2. Phase I
  3. Phase II
  4. Phase III & Registration
  5. Commercial & Post-approval
4. Market Analysis, Insights and Forecast – By Sponsor Type
  1. Small & Mid-sized Biotechnology Companies
  2. Large Pharmaceutical & Biopharmaceutical Companies
  3. Academic & Research Institutions
  4. Others
5. Market Analysis, Insights and Forecast – By Country
  1. U.S.
    1. By Virus
  2. Canada
    1. By Virus
Europe Oncolytic Virus CDMO Services Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Service Type
  1. Development & Technology-Transfer Services
  2. Cell & Virus Banking Services
  3. Manufacturing Services
  4. Analytical Testing & CMC Support Services
2. Market Analysis, Insights and Forecast – By Virus
  1. Adenoviridae
  2. Herpesviridae
  3. Poxviridae
  4. Reoviridae
  5. Others
3. Market Analysis, Insights and Forecast – By Development Stage
  1. Preclinical & IND-enabling
  2. Phase I
  3. Phase II
  4. Phase III & Registration
  5. Commercial & Post-approval
4. Market Analysis, Insights and Forecast – By Sponsor Type
  1. Small & Mid-sized Biotechnology Companies
  2. Large Pharmaceutical & Biopharmaceutical Companies
  3. Academic & Research Institutions
  4. Others
5. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. U.K.
    1. By Virus
  2. Germany
    1. By Virus
  3. France
    1. By Virus
  4. Spain
    1. By Virus
  5. Italy
    1. By Virus
  6. Scandinavia
    1. By Virus
  7. Rest of Europe
    1. By Virus
Asia Pacific Oncolytic Virus CDMO Services Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Service Type
  1. Development & Technology-Transfer Services
  2. Cell & Virus Banking Services
  3. Manufacturing Services
  4. Analytical Testing & CMC Support Services
2. Market Analysis, Insights and Forecast – By Virus
  1. Adenoviridae
  2. Herpesviridae
  3. Poxviridae
  4. Reoviridae
  5. Others
3. Market Analysis, Insights and Forecast – By Development Stage
  1. Preclinical & IND-enabling
  2. Phase I
  3. Phase II
  4. Phase III & Registration
  5. Commercial & Post-approval
4. Market Analysis, Insights and Forecast – By Sponsor Type
  1. Small & Mid-sized Biotechnology Companies
  2. Large Pharmaceutical & Biopharmaceutical Companies
  3. Academic & Research Institutions
  4. Others
5. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. Japan
    1. By Virus
  2. Australia
    1. By Virus
  3. China
    1. By Virus
  4. India
    1. By Virus
  5. Southeast Asia
    1. By Virus
  6. Rest of Asia Pacific
    1. By Virus
Latin America Oncolytic Virus CDMO Services Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Service Type
  1. Development & Technology-Transfer Services
  2. Cell & Virus Banking Services
  3. Manufacturing Services
  4. Analytical Testing & CMC Support Services
2. Market Analysis, Insights and Forecast – By Virus
  1. Adenoviridae
  2. Herpesviridae
  3. Poxviridae
  4. Reoviridae
  5. Others
3. Market Analysis, Insights and Forecast – By Development Stage
  1. Preclinical & IND-enabling
  2. Phase I
  3. Phase II
  4. Phase III & Registration
  5. Commercial & Post-approval
4. Market Analysis, Insights and Forecast – By Sponsor Type
  1. Small & Mid-sized Biotechnology Companies
  2. Large Pharmaceutical & Biopharmaceutical Companies
  3. Academic & Research Institutions
  4. Others
5. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. Brazil
    1. By Virus
  2. Mexico
    1. By Virus
  3. Rest of Latin America
    1. By Virus
Middle East & Africa Oncolytic Virus CDMO Services Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Service Type
  1. Development & Technology-Transfer Services
  2. Cell & Virus Banking Services
  3. Manufacturing Services
  4. Analytical Testing & CMC Support Services
2. Market Analysis, Insights and Forecast – By Virus
  1. Adenoviridae
  2. Herpesviridae
  3. Poxviridae
  4. Reoviridae
  5. Others
3. Market Analysis, Insights and Forecast – By Development Stage
  1. Preclinical & IND-enabling
  2. Phase I
  3. Phase II
  4. Phase III & Registration
  5. Commercial & Post-approval
4. Market Analysis, Insights and Forecast – By Sponsor Type
  1. Small & Mid-sized Biotechnology Companies
  2. Large Pharmaceutical & Biopharmaceutical Companies
  3. Academic & Research Institutions
  4. Others
5. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. South Africa
    1. By Virus
  2. GCC
    1. By Virus
  3. Rest of Middle East & Africa
    1. By Virus
Competitive Analysis
1. Global Market Share Analysis (2025)
2. Company Profiles (Overview, Products, SWOT analysis, Recent developments, strategies, financials (based on availability)
  1. FUJIFILM Biotechnologies (U.S.)
  2. Lonza Group AG (Switzerland)
  3. Recipharm AB (Sweden)
  4. IDT Biologika GmbH (Germany)
  5. WuXi Advanced Therapies (U.S.)
  6. ABL, Inc. (U.S.)
  7. uBriGene Biosciences Inc. (U.S.)
  8. OBiO Technology Corp., Ltd. (China)
  9. Exothera S.A. (Belgium)
  10. NAOBIOS (France)

Read Less

List of Figures

Figure 1: Global Oncolytic Virus CDMO Services Market Revenue Breakdown (USD million, %) by Region, 2025 & 2034

Figure 2: Global Oncolytic Virus CDMO Services Market Value Share (%), By Service Type, 2025 & 2034

Figure 3: Global Oncolytic Virus CDMO Services Market Value Share (%), By Virus, 2025 & 2034

Figure 4: Global Oncolytic Virus CDMO Services Market Value Share (%), by Development Stage, 2025 & 2034

Figure 5: Global Oncolytic Virus CDMO Services Market Value Share (%), By Sponsor Type, 2025 & 2034

Figure 7: Global Oncolytic Virus CDMO Services Market Value (USD million), by Region, 2025 & 2034

Figure 8: North America Oncolytic Virus CDMO Services Market Value (USD million), By Service Type, 2025 & 2034

Figure 9: North America Oncolytic Virus CDMO Services Market Value Share (%), By Service Type, 2025

Figure 10: North America Oncolytic Virus CDMO Services Market Value (USD million), By Virus, 2025 & 2034

Figure 11: North America Oncolytic Virus CDMO Services Market Value Share (%), By Virus, 2025

Figure 12: North America Oncolytic Virus CDMO Services Market Value (USD million), By Development Stage, 2025 & 2034

Figure 13: North America Oncolytic Virus CDMO Services Market Value Share (%), By Development Stage, 2025

Figure 14: North America Oncolytic Virus CDMO Services Market Value (USD million), By Sponsor Type, 2025 & 2034

Figure 15: North America Oncolytic Virus CDMO Services Market Value Share (%), By Sponsor Type, 2025

Figure 18: North America Oncolytic Virus CDMO Services Market Value (USD million), By Country, 2025 & 2034

Figure 19: North America Oncolytic Virus CDMO Services Market Value Share (%), By Country, 2025

Figure 20: Europe Oncolytic Virus CDMO Services Market Value (USD million), By Service Type, 2025 & 2034

Figure 21: Europe Oncolytic Virus CDMO Services Market Value Share (%), By Service Type, 2025

Figure 22: Europe Oncolytic Virus CDMO Services Market Value (USD million), By Virus, 2025 & 2034

Figure 23: Europe Oncolytic Virus CDMO Services Market Value Share (%), By Virus, 2025

Figure 24: Europe Oncolytic Virus CDMO Services Market Value (USD million), By Development Stage, 2025 & 2034

Figure 25: Europe Oncolytic Virus CDMO Services Market Value Share (%), By Development Stage, 2025

Figure 26: Europe Oncolytic Virus CDMO Services Market Value (USD million), By Sponsor Type, 2025 & 2034

Figure 27: Europe Oncolytic Virus CDMO Services Market Value Share (%), By Sponsor Type, 2025

Figure 30: Europe Oncolytic Virus CDMO Services Market Value (USD million), By Country/Sub-region, 2025 & 2034

Figure 31: Europe Oncolytic Virus CDMO Services Market Value Share (%), By Country/Sub-region, 2025

Figure 32: Asia Pacific Oncolytic Virus CDMO Services Market Value (USD million), By Service Type, 2025 & 2034

Figure 33: Asia Pacific Oncolytic Virus CDMO Services Market Value Share (%), By Service Type, 2025

Figure 34: Asia Pacific Oncolytic Virus CDMO Services Market Value (USD million), By Virus, 2025 & 2034

Figure 35: Asia Pacific Oncolytic Virus CDMO Services Market Value Share (%), By Virus, 2025

Figure 36: Asia Pacific Oncolytic Virus CDMO Services Market Value (USD million), By Development Stage, 2025 & 2034

Figure 37: Asia Pacific Oncolytic Virus CDMO Services Market Value Share (%), By Development Stage, 2025

Figure 38: Asia Pacific Oncolytic Virus CDMO Services Market Value (USD million), By Sponsor Type, 2025 & 2034

Figure 39: Asia Pacific Oncolytic Virus CDMO Services Market Value Share (%), By Sponsor Type, 2025

Figure 42: Asia Pacific Oncolytic Virus CDMO Services Market Value (USD million), By Country/Sub-region, 2025 & 2034

Figure 43: Asia Pacific Oncolytic Virus CDMO Services Market Value Share (%), By Country/Sub-region, 2025

Figure 44: Latin America Oncolytic Virus CDMO Services Market Value (USD million), By Service Type, 2025 & 2034

Figure 45: Latin America Oncolytic Virus CDMO Services Market Value Share (%), By Service Type, 2025

Figure 46: Latin America Oncolytic Virus CDMO Services Market Value (USD million), By Virus, 2025 & 2034

Figure 47: Latin America Oncolytic Virus CDMO Services Market Value Share (%), By Virus, 2025

Figure 48: Latin America Oncolytic Virus CDMO Services Market Value (USD million), By Development Stage, 2025 & 2034

Figure 49: Latin America Oncolytic Virus CDMO Services Market Value Share (%), By Development Stage, 2025

Figure 50: Latin America Oncolytic Virus CDMO Services Market Value (USD million), By Sponsor Type, 2025 & 2034

Figure 51: Latin America Oncolytic Virus CDMO Services Market Value Share (%), By Sponsor Type, 2025

Figure 54: Latin America Oncolytic Virus CDMO Services Market Value (USD million), By Country/Sub-region, 2025 & 2034

Figure 55: Latin America Oncolytic Virus CDMO Services Market Value Share (%), By Country/Sub-region, 2025

Figure 56: Middle East & Africa Oncolytic Virus CDMO Services Market Value (USD million), By Service Type, 2025 & 2034

Figure 57: Middle East & Africa Oncolytic Virus CDMO Services Market Value Share (%), By Service Type, 2025

Figure 58: Middle East & Africa Oncolytic Virus CDMO Services Market Value (USD million), By Virus, 2025 & 2034

Figure 59: Middle East & Africa Oncolytic Virus CDMO Services Market Value Share (%), By Virus, 2025

Figure 60: Middle East & Africa Oncolytic Virus CDMO Services Market Value (USD million), By Development Stage, 2025 & 2034

Figure 61: Middle East & Africa Oncolytic Virus CDMO Services Market Value Share (%), By Development Stage, 2025

Figure 62: Middle East & Africa Oncolytic Virus CDMO Services Market Value (USD million), By Sponsor Type, 2025 & 2034

Figure 63: Middle East & Africa Oncolytic Virus CDMO Services Market Value Share (%), By Sponsor Type, 2025

Figure 66: Middle East & Africa Oncolytic Virus CDMO Services Market Value (USD million), By Country/Sub-region, 2025 & 2034

Figure 67: Middle East & Africa Oncolytic Virus CDMO Services Market Value Share (%), By Country/Sub-region, 2025

Figure 68: Global Oncolytic Virus CDMO Services Market Share (%), By Company, 2025

List of Tables

Table 1: Global Oncolytic Virus CDMO Services Market Revenue (USD million) Forecast, By Service Type, 2021–2034

Table 2: Global Oncolytic Virus CDMO Services Market Revenue (USD million) Forecast, By Virus, 2021–2034

Table 3: Global Oncolytic Virus CDMO Services Market Revenue (USD million) Forecast, By Development Stage, 2021–2034

Table 4: Global Oncolytic Virus CDMO Services Market Revenue (USD million) Forecast, By Sponsor Type, 2021–2034

Table 5: Global Oncolytic Virus CDMO Services Market Revenue (USD million) Forecast, by Region, 2021- 2034

Table 6: North America Oncolytic Virus CDMO Services Market Revenue (USD million) Forecast, By Service Type, 2021–2034

Table 7: North America Oncolytic Virus CDMO Services Market Revenue (USD million) Forecast, By Virus, 2021–2034

Table 8: North America Oncolytic Virus CDMO Services Market Revenue (USD million) Forecast, By Development Stage, 2021–2034

Table 9: North America Oncolytic Virus CDMO Services Market Revenue (USD million) Forecast, By Sponsor Type, 2021–2034

Table 10: North America Oncolytic Virus CDMO Services Market Revenue (USD million) Forecast, by Country, 2021-2034

Table 11: U.S. Oncolytic Virus CDMO Services Market Revenue (USD million) Forecast, By Virus, 2021–2034

Table 12: Canada Oncolytic Virus CDMO Services Market Revenue (USD million) Forecast, By Virus, 2021–2034

Table 13: Europe Oncolytic Virus CDMO Services Market Revenue (USD million) Forecast, By Service Type, 2021–2034

Table 14: Europe Oncolytic Virus CDMO Services Market Revenue (USD million) Forecast, By Virus, 2021–2034

Table 15: Europe Oncolytic Virus CDMO Services Market Revenue (USD million) Forecast, By Development Stage, 2021–2034

Table 16: Europe Oncolytic Virus CDMO Services Market Revenue (USD million) Forecast, By Sponsor Type, 2021–2034

Table 17: Europe Oncolytic Virus CDMO Services Market Revenue (USD million) Forecast, by Country/Sub-region, 2021-2034

Table 18: U.K. Oncolytic Virus CDMO Services Market Revenue (USD million) Forecast, By Virus, 2021–2034

Table 19: Germany Oncolytic Virus CDMO Services Market Revenue (USD million) Forecast, By Virus, 2021–2034

Table 20: France Oncolytic Virus CDMO Services Market Revenue (USD million) Forecast, By Virus, 2021–2034

Table 21: Spain Oncolytic Virus CDMO Services Market Revenue (USD million) Forecast, By Virus, 2021–2034

Table 22: Italy Oncolytic Virus CDMO Services Market Revenue (USD million) Forecast, By Virus, 2021–2034

Table 23: Scandinavia Oncolytic Virus CDMO Services Market Revenue (USD million) Forecast, By Virus, 2021–2034

Table 24: Rest of Europe Oncolytic Virus CDMO Services Market Revenue (USD million) Forecast, By Virus, 2021–2034

Table 25: Asia Pacific Oncolytic Virus CDMO Services Market Revenue (USD million) Forecast, By Service Type, 2021–2034

Table 26: Asia Pacific Oncolytic Virus CDMO Services Market Revenue (USD million) Forecast, By Virus, 2021–2034

Table 27: Asia Pacific Oncolytic Virus CDMO Services Market Revenue (USD million) Forecast, By Development Stage, 2021–2034

Table 28: Asia Pacific Oncolytic Virus CDMO Services Market Revenue (USD million) Forecast, By Sponsor Type, 2021–2034

Table 29: Asia Pacific Oncolytic Virus CDMO Services Market Revenue (USD million) Forecast, by Country/Sub-region, 2021-2034

Table 30: Japan Oncolytic Virus CDMO Services Market Revenue (USD million) Forecast, By Virus, 2021–2034

Table 31: Australia Oncolytic Virus CDMO Services Market Revenue (USD million) Forecast, By Virus, 2021–2034

Table 32: China Oncolytic Virus CDMO Services Market Revenue (USD million) Forecast, By Virus, 2021–2034

Table 33: India Oncolytic Virus CDMO Services Market Revenue (USD million) Forecast, By Virus, 2021–2034

Table 34: Southeast Asia Oncolytic Virus CDMO Services Market Revenue (USD million) Forecast, By Virus, 2021–2034

Table 35: Rest of Asia Pacific Oncolytic Virus CDMO Services Market Revenue (USD million) Forecast, By Virus, 2021–2034

Table 36: Latin America Oncolytic Virus CDMO Services Market Revenue (USD million) Forecast, By Service Type, 2021–2034

Table 37: Latin America Oncolytic Virus CDMO Services Market Revenue (USD million) Forecast, By Virus, 2021–2034

Table 38: Latin America Oncolytic Virus CDMO Services Market Revenue (USD million) Forecast, By Development Stage, 2021–2034

Table 39: Latin America Oncolytic Virus CDMO Services Market Revenue (USD million) Forecast, By Sponsor Type, 2021–2034

Table 40: Latin America Oncolytic Virus CDMO Services Market Revenue (USD million) Forecast, by Country/Sub-region, 2021-2034

Table 41: Brazil Oncolytic Virus CDMO Services Market Revenue (USD million) Forecast, By Virus, 2021–2034

Table 42: Mexico Oncolytic Virus CDMO Services Market Revenue (USD million) Forecast, By Virus, 2021–2034

Table 43: Rest of Latin America Oncolytic Virus CDMO Services Market Revenue (USD million) Forecast, By Virus, 2021–2034

Table 44: Middle East & Africa Oncolytic Virus CDMO Services Market Revenue (USD million) Forecast, By Service Type, 2021–2034

Table 45: Middle East & Africa Oncolytic Virus CDMO Services Market Revenue (USD million) Forecast, By Virus, 2021–2034

Table 46: Middle East & Africa Oncolytic Virus CDMO Services Market Revenue (USD million) Forecast, By Development Stage, 2021–2034

Table 47: Middle East & Africa Oncolytic Virus CDMO Services Market Revenue (USD million) Forecast, By Sponsor Type, 2021–2034

Table 48: Middle East & Africa Oncolytic Virus CDMO Services Market Revenue (USD million) Forecast, by Country/Sub-region, 2021-2034

Table 49: GCC Oncolytic Virus CDMO Services Market Revenue (USD million) Forecast, By Virus, 2021–2034

Table 50: South Africa Oncolytic Virus CDMO Services Market Revenue (USD million) Forecast, By Virus, 2021–2034

Table 51: Rest of Middle East & Africa Oncolytic Virus CDMO Services Market Revenue (USD million) Forecast, By Virus, 2021–2034

STUDY PERIOD: 2021-2034
BASE YEAR: 2025
HISTORICAL DATA: 2021-2024
NO OF PAGES: 120

Buy Now

Download Free Sample

Get 30-60 hrs Free Customization

Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.

Growth Advisory Services

Clients

Related Reports

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

(APAC) +91 744 740 1245
sales@fortunebusinessinsights.com